This research analyses barriers and strategies for improving access to innovative therapies for rare bleeding disorders, with a focus on high-income countries. The findings offer actionable insights for stakeholders across healthcare systems.
Presented at ISPOR EU 2024, Barcelona, Spain.
Please click here to download the poster. Don’t forget to subscribe to our newsletter below for the latest company updates, recently published HTA guidance, industry insights, and more!